139 related articles for article (PubMed ID: 28823501)
1. Quality of life metrics in arrhythmogenic right ventricular cardiomyopathy patients: The impact of age, shock and sex.
Rhodes AC; Murray B; Tichnell C; James CA; Calkins H; Sears SF
Int J Cardiol; 2017 Dec; 248():216-220. PubMed ID: 28823501
[TBL] [Abstract][Full Text] [Related]
2. General and disease-specific psychosocial adjustment in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy with implantable cardioverter defibrillators: a large cohort study.
James CA; Tichnell C; Murray B; Daly A; Sears SF; Calkins H
Circ Cardiovasc Genet; 2012 Feb; 5(1):18-24. PubMed ID: 22238189
[TBL] [Abstract][Full Text] [Related]
3. The impact of technology dependency on device acceptance and quality of life in persons with implantable cardioverter defibrillators.
Udlis KA
J Cardiovasc Nurs; 2013; 28(6):E65-73. PubMed ID: 23348222
[TBL] [Abstract][Full Text] [Related]
4. Survival After Heart Transplantation in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
DePasquale EC; Cheng RK; Deng MC; Nsair A; McKenna WJ; Fonarow GC; Jacoby DL
J Card Fail; 2017 Feb; 23(2):107-112. PubMed ID: 27154489
[TBL] [Abstract][Full Text] [Related]
5. Clinical Presentation and Outcomes by Sex in Arrhythmogenic Right Ventricular Cardiomyopathy: Findings from the North American ARVC Registry.
Choudhary N; Tompkins C; Polonsky B; McNitt S; Calkins H; Mark Estes NA; Krahn AD; Link MS; Marcus FI; Towbin JA; Zareba W
J Cardiovasc Electrophysiol; 2016 May; 27(5):555-62. PubMed ID: 26840461
[TBL] [Abstract][Full Text] [Related]
6. Heart transplantation in arrhythmogenic right ventricular cardiomyopathy - Experience from the Nordic ARVC Registry.
Gilljam T; Haugaa KH; Jensen HK; Svensson A; Bundgaard H; Hansen J; Dellgren G; Gustafsson F; Eiskjær H; Andreassen AK; Sjögren J; Edvardsen T; Holst AG; Svendsen JH; Platonov PG
Int J Cardiol; 2018 Jan; 250():201-206. PubMed ID: 29107359
[TBL] [Abstract][Full Text] [Related]
7. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.
Corrado D; Leoni L; Link MS; Della Bella P; Gaita F; Curnis A; Salerno JU; Igidbashian D; Raviele A; Disertori M; Zanotto G; Verlato R; Vergara G; Delise P; Turrini P; Basso C; Naccarella F; Maddalena F; Estes NA; Buja G; Thiene G
Circulation; 2003 Dec; 108(25):3084-91. PubMed ID: 14638546
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic expression is a prerequisite for malignant arrhythmic events and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy.
Zorzi A; Rigato I; Pilichou K; Perazzolo Marra M; Migliore F; Mazzotti E; Gregori D; Thiene G; Daliento L; Iliceto S; Rampazzo A; Basso C; Bauce B; Corrado D
Europace; 2016 Jul; 18(7):1086-94. PubMed ID: 26138720
[TBL] [Abstract][Full Text] [Related]
9. The ventricular ectopic QRS interval (VEQSI): Diagnosis of arrhythmogenic right ventricular cardiomyopathy in patients with incomplete disease expression.
Bastiaenen R; Pantazis A; Gonna H; Chis-Ster I; Castelletti S; Batchvarov VN; Domenichini G; Coccolo F; Boriani G; McKenna WJ; Behr ER; Gallagher MM
Heart Rhythm; 2016 Jul; 13(7):1504-12. PubMed ID: 27016477
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Performance of Right Ventricular Implantable Cardioverter-Defibrillator Leads in Arrhythmogenic Right Ventricular Cardiomyopathy and Hypertrophic Cardiomyopathy.
Sagawa Y; Nagata Y; Yamaguchi T; Mitsui K; Nagamine T; Yamaguchi J; Hijikata S; Watanabe K; Masuda R; Miyazaki R; Kaneko M; Miwa N; Sekigawa M; Hara N; Nozato T; Ashikaga T; Goya M; Sasano T; Hirao K
Int Heart J; 2020 Jan; 61(1):39-45. PubMed ID: 31956141
[TBL] [Abstract][Full Text] [Related]
11. Electrical Storm in ICD Recipients with Arrhythmogenic Right Ventricular Cardiomyopathy.
Yin K; Ding L; Hua W; Zhang S
Pacing Clin Electrophysiol; 2017 Jun; 40(6):683-692. PubMed ID: 28261825
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
Li CH; Lin YJ; Huang JL; Wu TJ; Cheng CC; Lin WS; Tuan TC; Chang SL; Lo LW; Hu YF; Chao TF; Chung FP; Tsai CF; Tsao HM; Chen SA
J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378
[TBL] [Abstract][Full Text] [Related]
13. High Arrhythmic Burden but Low Mortality during Long-term Follow-up in Arrhythmogenic Right Ventricular Cardiomyopathy.
Martin A; Crawford J; Skinner JR; Smith W;
Heart Lung Circ; 2016 Mar; 25(3):275-81. PubMed ID: 26546095
[TBL] [Abstract][Full Text] [Related]
14. Disease-specific quality of life-patient acceptance: racial and gender differences in patients with implantable cardioverter defibrillators.
Wilson MH; Engelke MK; Sears SF; Swanson M; Neil JA
J Cardiovasc Nurs; 2013; 28(3):285-93. PubMed ID: 22580627
[TBL] [Abstract][Full Text] [Related]
15. Implantable Cardioverter-Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications.
Orgeron GM; James CA; Te Riele A; Tichnell C; Murray B; Bhonsale A; Kamel IR; Zimmerman SL; Judge DP; Crosson J; Tandri H; Calkins H
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28588093
[TBL] [Abstract][Full Text] [Related]
16. The Registry Evaluating Functional Outcomes of Resynchronization Management (REFORM): quality of life and psychological functioning in patients receiving cardiac resynchronization therapy.
Ford J; Sears S; Ramza B; Reynolds DW; Nguyen P; Fedewa M; House J; Kennedy P; Thompson R; Murray C
J Cardiovasc Electrophysiol; 2014 Jan; 25(1):43-51. PubMed ID: 24102945
[TBL] [Abstract][Full Text] [Related]
17. Cardiac phenotype and long-term prognosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia patients with late presentation.
Bhonsale A; Te Riele ASJM; Sawant AC; Groeneweg JA; James CA; Murray B; Tichnell C; Mast TP; van der Pols MJ; Cramer MJM; Dooijes D; van der Heijden JF; Tandri H; van Tintelen JP; Judge DP; Hauer RNW; Calkins H
Heart Rhythm; 2017 Jun; 14(6):883-891. PubMed ID: 28215569
[TBL] [Abstract][Full Text] [Related]
18. Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia (ARVC/D): Review of 16 Pediatric Cases and a Proposal of Modified Pediatric Criteria.
Deshpande SR; Herman HK; Quigley PC; Shinnick JK; Cundiff CA; Caltharp S; Shehata BM
Pediatr Cardiol; 2016 Apr; 37(4):646-55. PubMed ID: 26743400
[TBL] [Abstract][Full Text] [Related]
19. Arrhythmogenic Right Ventricular Cardiomyopathy: Risk Stratification and Indications for Defibrillator Therapy.
Zorzi A; Rigato I; Bauce B; Pilichou K; Basso C; Thiene G; Iliceto S; Corrado D
Curr Cardiol Rep; 2016 Jun; 18(6):57. PubMed ID: 27147509
[TBL] [Abstract][Full Text] [Related]
20. Psychological wellbeing and posttraumatic stress associated with implantable cardioverter defibrillator therapy in young adults with genetic heart disease.
Ingles J; Sarina T; Kasparian N; Semsarian C
Int J Cardiol; 2013 Oct; 168(4):3779-84. PubMed ID: 23835269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
